Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?

Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?

Bibliographic Details
Main Authors:	Leonor Kremer, Jose A. Garcia-Sanz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-03-01
Series:	Frontiers in Immunology
Subjects:	antitumor therapeutic antibodies antibodies in combinations effective cancer therapies therapeutic antibodies immunotherapy
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2018.00442/full

Similar Items

New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness
by: Isabel Corraliza-Gorjón, et al.
Published: (2017-12-01)

Editorial: Antibody Fc Engineering: Towards Better Therapeutics
by: Cheng Lei, et al.
Published: (2018-10-01)

92R Monoclonal Antibody Inhibits Human CCR9+ Leukemia Cells Growth in NSG Mice Xenografts
by: Beatriz Somovilla-Crespo, et al.
Published: (2018-01-01)

Editorial: Single-Domain Antibodies—Biology, Engineering and Emerging Applications
by: Kevin A. Henry, et al.
Published: (2018-01-01)

Bispecific antibodies: design, therapy, perspectives
by: Sedykh SE, et al.
Published: (2018-01-01)

Chemokine receptor specific antibodies in cancer immunotherapy: achievements and challenges
by: Maria eVela, et al.
Published: (2015-01-01)

Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer
by: Mariam Elshiaty, et al.
Published: (2021-05-01)

Development of therapeutic antibodies for the treatment of diseases
by: Ruei-Min Lu, et al.
Published: (2020-01-01)

Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
by: Kevin O. Saunders
Published: (2019-06-01)

Restoring Innate NK-cell Immunity with Antibody Therapeutics in CLL B-Cell Malignancy
by: McWilliams, Emily Mary
Published: (2016)

Improvement of Biophysical Properties and Affinity of a Human Anti-L1CAM Therapeutic Antibody through Antibody Engineering Based on Computational Methods
by: Heesu Chae, et al.
Published: (2021-06-01)

Natural and Man-made Antibody Repertories for Antibody Discovery
by: Juan C eAlmagro
Published: (2012-11-01)

NK cell mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
by: Wei eWang, et al.
Published: (2015-07-01)

Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions
by: Yu Tang, et al.
Published: (2021-03-01)

Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?
by: Claire Deligne, et al.
Published: (2017-08-01)

Recent progress in the molecular imaging of therapeutic monoclonal antibodies
by: Kaifeng He, et al.
Published: (2020-10-01)

Commentary: Immunology's Coming of Age
by: Heinz Kohler, et al.
Published: (2019-09-01)

In Vitro Evolution of Antibodies Inspired by In Vivo Evolution
by: Helena Persson, et al.
Published: (2018-06-01)

Identification of a novel cancer therapeutic antibody against human epidermal growth factor receptor 2 (Her2) and antibody engineering for development of cancer therapeutics
by: Chen, Chao, et al.
Published: (2014)

Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
by: Mehdi Arbabi-Ghahroudi, et al.
Published: (2017-11-01)

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
by: Peter Bannas, et al.
Published: (2017-11-01)

Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy–Focus on FcγRIIB
by: Ingrid Teige, et al.
Published: (2019-03-01)

Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies
by: Maria Gabriella Donà, et al.
Published: (2021-08-01)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
by: Vincent Dussupt, et al.
Published: (2021-02-01)

Antibody therapy of pediatric B-cell lymphoma
by: Friederike eMeyer-Wentrup, et al.
Published: (2013-04-01)

Producing and prospects for the use of bispecific antibodies for the treatment of cancer
by: S. E. Sedykh, et al.
Published: (2019-01-01)

Regulatory Approved Monoclonal Antibodies Contain Framework Mutations Predicted From Human Antibody Repertoires
by: Brian M. Petersen, et al.
Published: (2021-09-01)

Evaluation of Antibody-based Therapeutics in B cell Malignancies
by: Rafiq, Sarwish
Published: (2012)

Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Children: Application of Allometric Scaling
by: Iftekhar Mahmood
Published: (2020-08-01)

Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
by: Kyusang Hwang, et al.
Published: (2021-01-01)

Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?
by: Silvia Santamaria, et al.
Published: (2017-11-01)

Antibody Targeting of Eph Receptors in Cancer
by: Peter W. Janes, et al.
Published: (2020-05-01)

Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition
by: Imran Siddiqui, et al.
Published: (2018-02-01)

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
by: Joanna Macdonald, et al.
Published: (2018-01-01)

Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies
by: Josée Golay, et al.
Published: (2020-05-01)

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies
by: Casey K. Hua, et al.
Published: (2017-11-01)

Natural killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) in tumour immunotherapy with therapeutic antibodies
by: Ursula Jördis Eva Seidel, et al.
Published: (2013-03-01)

Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity
by: Charles D. Murin
Published: (2020-07-01)

A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model
by: Guang Wu, et al.
Published: (2018-07-01)

Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
by: Charles D. Murin, et al.
Published: (2021-04-01)